Spero Therapeutics, Inc 10-K for FY2024
Spero Therapeutics, Inc. (SPRO)
10-K
2025-03-27
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 10-K
Spero Therapeutics, Inc filed this 10-K on March 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $47.98M
- down 53.8% from $103.78M a year earlier
- Net loss
- $68.57M
- compared with net income of $22.81M a year earlier
- Diluted EPS
- -$1.27
- compared with $0.43 a year earlier